No matter how many times it’s been settled throughout history, one of the most basic questions in economics keeps popping up again and again, as if for the first time. Why do things cost what they cost? Once again this question is being pondered, this time by researchers in the field of drug prices in multiple sclerosis. Once again, researchers are reinventing the wheel.
Published in the journal Neurology over Thanksgiving weekend, four researchers from Oregon State University sought out to discover the reasons behind pricing dynamics in MS. The question could just as easily